ArticlePloS one2014
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.
- Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association.The Journal of pathology · 2019Guideline
- Biological feature-based machine learning in histopathological images: a systematic review.Journal of pathology informatics · 2026Review
- NLTD 2.0: A Nonlinear Framework for Robust and Customizable Color Deconvolution in Histopathology.bioRxiv : the preprint server for biology · 2025Article
- Computational pathology: A survey review and the way forward.Journal of pathology informatics · 2024Review
- Advancing Patient Care: How Artificial Intelligence Is Transforming Healthcare.Journal of personalized medicine · 2023Review
- Multicenter automatic detection of invasive carcinoma on breast whole slide images.PLOS digital health · 2023Article
- Artificial intelligence applied to breast pathology.Virchows Archiv : an international journal of pathology · 2022Review
- A dual decoder U-Net-based model for nuclei instance segmentation in hematoxylin and eosin-stained histological images.Frontiers in medicine · 2022Article
- Deep Learning on Oral Squamous Cell Carcinoma Ex Vivo Fluorescent Confocal Microscopy Data: A Feasibility Study.Journal of clinical medicine · 2021Article
- Automatic Whole Slide Pathology Image Diagnosis Framework via Unit Stochastic Selection and Attention Fusion.Neurocomputing · 2021Article
- Improving DCIS diagnosis and predictive outcome by applying artificial intelligence.Biochimica et biophysica acta. Reviews on cancer · 2021Review
- Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer.JNCI cancer spectrum · 2021Article
- Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications.Frontiers in oncology · 2021Review
- Morphological Estimation of Cellularity on Neo-Adjuvant Treated Breast Cancer Histological Images.Journal of imaging · 2020Article
- Derivation of a nuclear heterogeneity image index to grade DCIS.Computational and structural biotechnology journal · 2020Article
- Tabu Search and Machine-Learning Classification of Benign and Malignant Proliferative Breast Lesions.BioMed research international · 2020Review
- Using Image Registration and Machine Learning to Develop a Workstation Tool for Rapid Analysis of Glomeruli in Medical Renal Biopsies.Journal of pathology informatics · 2020Article
- Review
- Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.JAMA network open · 2019Article
- Digital Assessment of Stained Breast Tissue Images for Comprehensive Tumor and Microenvironment Analysis.Frontiers in bioengineering and biotechnology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 1 country.
Funding
Abstract
The categorization of intraductal proliferative lesions of the breast based on routine light microscopic examination of histopathologic sections is in many cases challenging, even for experienced pathologists. The development of computational tools to aid pathologists in the characterization of these lesions would have great diagnostic and clinical value. As a first step to address this issue, we evaluated the ability of computational image analysis to accurately classify DCIS and UDH and to stratify nuclear grade within DCIS. Using 116 breast biopsies diagnosed as DCIS or UDH from the Massachusetts General Hospital (MGH), we developed a computational method to extract 392 features corresponding to the mean and standard deviation in nuclear size and shape, intensity, and texture across 8 color channels. We used L1-regularized logistic regression to build classification models to discriminate DCIS from UDH. The top-performing model contained 22 active features and achieved an AUC of 0.95 in cross-validation on the MGH data-set. We applied this model to an external validation set of 51 breast biopsies diagnosed as DCIS or UDH from the Beth Israel Deaconess Medical Center, and the model achieved an AUC of 0.86. The top-performing model contained active features from all color-spaces and from the three classes of features (morphology, intensity, and texture), suggesting the value of each for prediction. We built models to stratify grade within DCIS and obtained strong performance for stratifying low nuclear grade vs. high nuclear grade DCIS (AUC = 0.98 in cross-validation) with only moderate performance for discriminating low nuclear grade vs. intermediate nuclear grade and intermediate nuclear grade vs. high nuclear grade DCIS (AUC = 0.83 and 0.69, respectively). These data show that computational pathology models can robustly discriminate benign from malignant intraductal proliferative lesions of the breast and may aid pathologists in the diagnosis and classification of these lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.